Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study

✍ Scribed by Aatke van der Maas, Bart JF van den Bemt, Gertjan Wolbink, Frank HJ van den Hoogen, Piet LCM van Riel, Alfons A den Broeder

• Book ID: 119898859
• Publisher: BioMed Central
• Year: 2012
• Tongue: English
• Weight: 162 KB
• Volume: 13
• Category: Article
• ISSN: 1471-2474
• DOI: 10.1186/1471-2474-13-184